Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.59 |
| ▸ | APEX1 | P27695 | 9/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | RXRG | P48443 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3736899 | 1.00 | AKR1C3 (0.59) | AKR1C3APEX1ALDH1A1TSHRKDM4E | |
| SCHEMBL7134074 | 0.88 | AKR1C3 (0.47) | AKR1C3APEX1ALDH1A1TSHRKDM4E | |
| SCHEMBL31666241 | 0.87 | AKR1C3 (0.68) | AKR1C3APEX1KDM4ELMNAHTT | |
| SCHEMBL3893886 | 0.87 | AKR1C3 (0.68) | AKR1C3APEX1KDM4ELMNAHTT | |
| SCHEMBL8746671 | 0.87 | AKR1C3 (0.68) | AKR1C3APEX1KDM4ELMNAHTT | |
| SCHEMBL2439822 | 0.86 | ALDH1A1 (0.50) | AKR1C3ALDH1A1TSHRKDM4EGMNN | |
| SCHEMBL17122439 | 0.86 | ALDH1A1 (0.50) | AKR1C3ALDH1A1TSHRKDM4EGMNN | |
| SCHEMBL2439824 | 0.86 | ALDH1A1 (0.50) | AKR1C3ALDH1A1TSHRKDM4EGMNN | |
| SCHEMBL13287298 | 0.86 | ALDH1A1 (0.50) | AKR1C3ALDH1A1TSHRKDM4EGMNN | |
| SCHEMBL22042820 | 0.85 | AKR1C3 (0.52) | AKR1C3APEX1ALDH1A1TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0458082-B1 | Encapsulated toner compositions | XEROX CORP (US) | 1996-09-04 | — | — | EP | claimed |
| US-11896593-B2 | Sulfamate derivative compounds for use in treating or alleviating a psychiatric disorder | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2024-02-13 | — | — | US | disclosed |
| US-11795151-B2 | Benzotriazole compound | MIYOSHI OIL & FAT CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| EP-4211125-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER | Bio-Pharm Solutions Co., Ltd. (KR) | 2023-07-19 | — | — | EP | disclosed |
| US-20220218702-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2022-07-14 | — | — | US | disclosed |
| EP-2574976-B1 | Ophthalmic devices having a highly selective violet light transmissive filter | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20200325107-A1 | BENZOTRIAZOLE COMPOUND | MIYOSHI OIL & FAT CO., LTD. (JP) | 2020-10-15 | — | — | US | disclosed |
| US-10481314-B2 | Display apparatus and polarizer thereof | LG DISPLAY CO., LTD. (KR) | 2019-11-19 | — | — | US | disclosed |
| EP-3517571-A1 | (METH)ACRYLIC COPOLYMER, RESIN COMPOSITION, MOLDED BODY OF SAME, AND METHOD FOR PRODUCING MOLDED BODY | Mitsubishi Gas Chemical Company, Inc. (JP) | 2019-07-31 | — | — | EP | disclosed |
| EP-3443959-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN | Bio-Pharm Solutions Co., Ltd. (KR) | 2019-02-20 | — | — | EP | disclosed |
| WO-2004015020-A1 | ADHESIVE MATERIALS HAVING A HIGH REFRACTIVE INDEX BASED ON ACRYLATE BLOCK COPOLYMERS | TESA AG (DE) | 2004-02-19 | — | — | WO | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-5821306-A | POLYMER BLEND CONSISTING OF POLYPHENYLETHYL METHACRYLATE AND POLYPHENYLETHYL ACRYLATE | PHARMACIA & UPJOHN GRONINGEN BV (NL) | 1998-10-13 | — | — | US | disclosed |
| US-5691094-A | LITHOGRAPHY, INPROVED TRANSFERABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1997-11-25 | — | — | US | disclosed |
| EP-0784652-A1 | INTRAOCULAR LENS MATERIALS | Pharmacia & Upjohn Aktiebolag (SE) | 1997-07-23 | — | — | EP | disclosed |
| US-5648191-A | Method for preparation of printing plate by electrophotographic process | FUJI PHOTO FILM CO., LTD. (JP) | 1997-07-15 | — | — | US | disclosed |
| US-5597672-A | Method for preparation of printing plate by electrophotographic process | FUJI PHOTO FILM CO., LTD. (JP) | 1997-01-28 | — | — | US | disclosed |
| WO-1996011235-A1 | INTRAOCULAR LENS MATERIALS | PHARMACIA & UPJOHN AB (SE) | 1996-04-18 | — | — | WO | disclosed |
| US-5501929-A | TONER IMAGES ON TRANSFER LAYER OF THERMOPLASTIC RESIN FORLIGHT SENSITIVE ELEMENT | FUJI PHOTO FILM CO., LTD. (JP) | 1996-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220218702-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER | SLC6A4, SLC6A3, SLC6A2 | AKR1C3 4119/4885APEX1 3885/4885ALDH1A1 776/4885 |
| US-11795151-B2 | Benzotriazole compound | PRXL2A, HAX1, XRN2 | AKR1C3 4016/4885APEX1 2120/4885ALDH1A1 2237/4885 |
| US-11896593-B2 | Sulfamate derivative compounds for use in treating or alleviating a psychiatric disorder | SLC6A4, SLC6A3, SLC6A2 | AKR1C3 4119/4885APEX1 3885/4885ALDH1A1 776/4885 |
| US-20200325107-A1 | BENZOTRIAZOLE COMPOUND | PRXL2A, HAX1, XRN2 | AKR1C3 4016/4885APEX1 2120/4885ALDH1A1 2237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.